Medication Adherence and Its Associated Factors Among Type II Diabetes Mellitus Patients Presenting to Health Centres in Tirupati, Andhra Pradesh, India

Ajeetha B; Anju  Damu Ade; Visweswara Rao Guthi; Lalith Meesala

doi:10.55489/njcm.160120254691

Authors

Ajeetha B Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, India
Anju Damu Ade Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, India
Visweswara Rao Guthi Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, India
Lalith Meesala Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, India

DOI:

https://doi.org/10.55489/njcm.160120254691

Keywords:

Type 2 Diabetes Mellitus, Medication Non-adherence, Hill-Bone Medication Adherence Scale, Primary health centres, Secondary health centres

Abstract

Background: Diabetes is a swiftly expanding health issue. To avoid or postpone the development of complications, patients need to adherent to their antidiabetic drugs. The objective was to assess medication adherence and to determine the association between medication non-adherence and socio-demographic characteristics, co-morbidities, and self-care and medication practices among Type II Diabetes Mellitus patients.

Methods: An analytical cross-sectional study was conducted among 216 diabetic patients of more than 18 years of age with duration at least 6 months presenting to the 4 health centres in Tirupati. Medication adherence was assessed using the nine-item Hill-Bone Medication Adherence Scale (HBMAS).

Results: The study found that among the 216 participants, 82.9% were adherent while 17.1% were non-adherent to medications. On multivariate analysis, age group of >60 years (AOR=2.97(95% CI 1.158-7.662), belonging to rural areas (AOR=22.163 (95% CI:2.404-193.678), not following any dietary modifications (AOR= 2.976 (95% CI 0.935-9.479) and dependent on family member for medication intake remembrance (AOR=6.103(0.875-42.546) were found to be more at risk for non-adherence.

Conclusions: One-fifth of the study participants were non-adherent to medications. Increasing age, rural population, not following dietary modifications, and dependent on family members to remind them for medication intake were found to be associated with medication non-adherence.

References

World Health Organization. Diabetes. Available at: https://www.who.int/health-topics/diabetes. [Accessed on April 28th, 2024].

Mathur P, Leburu S, Kulothungan V. Prevalence, Awareness, Treatment and Control of Diabetes in India From the Countrywide National NCD Monitoring Survey. Front Public Health. 2022;10:748157. DOI: https://doi.org/10.3389/fpubh.2022.748157 PMid:35359772 PMCid:PMC8964146

International diabetes federation. IDF; 2021. Available at: https://diabetesatlas.org/resources/?gclid=Cj0KCQiAqOucBhDrARIsAPCQL1bVLnOBqbdaIG0Ijxm0awHAsK8RIbGgj1HQFcJu%20qp_9ygELLafX0foaAmBREALw_wcB.[Accessed on April 27th, 2024].

International Institute for Population Sciences (IIPS) and ICF. 2021. National Family Health Survey (NFHS-5), India, 2019-21: India Fact sheet. Available at https://rchiips.org/nfhs/NFHS-5_FCTS/India.pdf.[Accessed on April, 27th, 2024].

Sharma D, Goel NK, Cheema YS, Garg K. Medication Adherence and its Predictors among Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study. Indian J Community Med. 2023;48(5):781-785. DOI: https://doi.org/10.4103/ijcm.ijcm_744_22 PMid:37970170 PMCid:PMC10637603

Mishra A, Pradhan SK, Sahoo BK, Das A, Singh AK, Parida SP. Assessment of Medication Adherence and Associated Factors Among Patients with Diabetes Attending a Non-communicable Disease Clinic in a Community Health Centre in Eastern India. Cureus. 2023;15(8):e43779. DOI: https://doi.org/10.7759/cureus.43779

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. DOI: https://doi.org/10.2337/diacare.27.5.1047 PMid:15111519

Ranasinghe P, Jayawardena R, Gamage N, Sivanandam N, Misra A. Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Ann Epidemiol. 2021;58:128-148. DOI: https://doi.org/10.1016/j.annepidem.2021.02.016 PMid:33727086

National Non-communicable Disease Monitoring Survey (NNMS) 2017-18. (2018). Available at https://www.ncdirindia.org/nnms/resources/NNMS 2017-18-Report.pdf. [Accessed on April, 28th, 2024].

Kaur P, Gomra R, Girdhar S, Sharma S, Chaudhary A. A qualitative study on factors affecting adherence to antidiabetic medication in patients approaching a health center in an urban area. J Family Med Prim Care 2023;12(8):1602-8. DOI: https://doi.org/10.4103/jfmpc.jfmpc_2107_22 PMid:37767450 PMCid:PMC10521832

World Health Organization. Adherence to long-term therapies (2003). Available at: https://iris.who.int/bitstream/handle/10665/42682/9241545992.pdf. [Accessed on April, 27th, 2024].

Chin SS, Lau SW, Lim PL, Wong CM, Ujang N. Medication adherence, its associated factors and implication on glycaemic control in patients with type 2 diabetes mellitus: A cross-sectional study in a Malaysian primary care clinic. Malays Fam Physician 2023;18(14):1-11. DOI: https://doi.org/10.51866/oa.88 PMid:37139478 PMCid:PMC10150324

Krousel Wood M, Muntner P, Jannu A, Desalvo, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330(3):128-133. DOI: https://doi.org/10.1097/00000441-200509000-00006 PMid:16174996

Alqarni AM, Alrahbeni T, Al Qarni A, Al Qarni HM. Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia-A cross-sectional survey. Patient Prefer Adherence. 2018;13:63-71. DOI: https://doi.org/10.2147/PPA.S176355 PMid:30636871 PMCid:PMC6309134

Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-1307. DOI: https://doi.org/10.2147/PPA.S106821 PMid:27524885 PMCid:PMC4966497

Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000 Summer;15(3):90-6. DOI: https://doi.org/10.1111/j.1751-7117.2000.tb00211.x PMid:10951950

Onwuchuluba EE, Oyetunde OO, Soremekun RO. Medication adherence in type 2 diabetes mellitus: A qualitative exploration of barriers and facilitators from socioecological perspectives. J Patient Exp 2021;8:23743735211034338. DOI: https://doi.org/10.1177/23743735211034338 PMid:34368436 PMCid:PMC8317237

Sahoo J, Mohanty S, Kundu A, Epari V. Medication adherence among patients of type II diabetes mellitus and its associated risk factors: A cross-sectional study in a tertiary care hospital of eastern India. Cureus. 2022;14(12):e33074. DOI: https://doi.org/10.7759/cureus.33074

Swain SP, Samal S, Sahu KS, Rout SK. Out-of-pocket expenditure and drug adherence of patients with diabetes in Odisha. J Family Med Prim Care. 2018;7(6):1229-35. DOI: https://doi.org/10.4103/jfmpc.jfmpc_24_18 PMid:30613502 PMCid:PMC6293900

Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006 Winter;16(1):286-91.

Kim E-Y, Han H-R, Jeong S, Kim KB, Park H, Kang E, et al. Does knowledge matter?: intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs. 2007;22(5):397-404. DOI: https://doi.org/10.1097/01.JCN.0000287038.23186.bd PMid:17724422

Afaya RA, Bam V, Azongo TB, Afaya A, Kusi-Amponsah A, Ajusiyine JM, et al. Medication adherence and self-care behaviours among patients with type 2 diabetes mellitus in Ghana. PLoS One 2020;15(8):e0237710. DOI: https://doi.org/10.1371/journal.pone.0237710 PMid:32822381 PMCid:PMC7446850

Aminde LN, Tindong M, Ngwasiri CA, Aminde JA, Njim T, Fondong AA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):35. DOI: https://doi.org/10.1186/s12902-019-0360-9 PMid:30943969 PMCid:PMC6446302

S. Padmanabha UR, R. M, Hiremath S, N. P, Prithviraj R. A study to assess the treatment adherence among patients with type 2 diabetes mellitus in rural and urban population of Bengaluru, South India. Int J Community Med Public Health. 2020;7(8):3105-10. DOI: https://doi.org/10.18203/2394-6040.ijcmph20203385

Venkatesan M, Dongre AR, Ganapathy K. A community-based study on diabetes medication nonadherence and its risk factors in rural Tamil Nadu. Indian J Community Med 2018;43:72-6. DOI: https://doi.org/10.4103/ijcm.IJCM_261_17 PMid:29899603 PMCid:PMC5974838

Bagonza J, Rutebemberwa E, Bazeyo W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res. 2015;15:168. DOI: https://doi.org/10.1186/s12913-015-0820-5 PMid:25898973 PMCid:PMC4405852

Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient preference and adherence. 2013;7:525-30. DOI: https://doi.org/10.2147/PPA.S44698 PMid:23814461 PMCid:PMC3693921

Shams N, Amjad S, Kumar N, Ahmed W, Saleem F. Drug Non-Adherence in Type 2 Diabetes Mellitus; Predictors And Associations. J Ayub Med Coll Abbottabad. 2016;28(2):302-07.